Magellan Health (NASDAQ:MGLN) reported Q4 2017 earnings this Morning, coming in at $2.55 per share, beating Wall Street’s estimates of $2.29 per Share. Revenue for the quarter came in at $1.69 billion beating analyst estimates of $1.62 billion Recent Insider Trading for Magellan Health (NASDAQ:MGLN)
- On 2/1/2018 Barry M Smith, CEO, sold 13,375 with an average share price of $99.20 per share and the total transaction amounting to $1,326,800.00.
- On 1/2/2018 Barry M Smith, CEO, sold 13,367 with an average share price of $95.94 per share and the total transaction amounting to $1,282,429.98.
- On 1/2/2018 Jonathan N Rubin, CFO, sold 17,443 with an average share price of $96.07 per share and the total transaction amounting to $1,675,749.01.
- On 12/4/2017 Clapper Caskie Lewis, Insider, sold 59,313 with an average share price of $93.99 per share and the total transaction amounting to $5,574,828.87.
- On 12/4/2017 Mostafa Kamal, CEO, sold 2,180 with an average share price of $92.00 per share and the total transaction amounting to $200,560.00.
- On 12/1/2017 Daniel N Gregoire, General Counsel, sold 8,275 with an average share price of $89.08 per share and the total transaction amounting to $737,137.00.
Recent Trading for Magellan Health (NASDAQ:MGLN) Shares of Magellan Health closed the previous trading session at 104.95 up +8.00 8.25% with 101.44999694824219 shares trading hands.